Acute leukemia of ambiguous lineage Advocacy Hub | UniteRare

At a Glance

Live from database

🔬

Regulatory Watchboard

10 events

Jun 2026Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

Fred Hutchinson Cancer Center — NA

TrialNOT YET RECRUITING

Sep 2025Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

Fred Hutchinson Cancer Center — PHASE2

TrialRECRUITING

Jun 2025Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

National Cancer Institute (NCI) — PHASE2

TrialRECRUITING

Jul 2024Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Fred Hutchinson Cancer Center — PHASE2

TrialRECRUITING

Jan 2024A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia

Children's Oncology Group — PHASE2

TrialACTIVE NOT RECRUITING

Jul 2023Venetoclax Combined With Azactidine in the Treatment of ALAL

Sheng-Li Xue, MD — PHASE2

TrialRECRUITING

May 2023MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota — PHASE2

TrialRECRUITING

Feb 2022A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Sumitomo Pharma America, Inc. — PHASE1, PHASE2

TrialRECRUITING

Nov 2021Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

St. Jude Children's Research Hospital — PHASE1

TrialACTIVE NOT RECRUITING

Apr 2021AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

Mitchell Cairo — PHASE2

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance1

Revuforj

Syndax Pharmaceuticals

OpenContact for detailsApply ↗

View all support programs on disease page →

Clinical Trial Landscape

12 active trials

8Phase 2

2Phase 1

2N/A

12Total recruiting

Search clinical trials for Acute leukemia of ambiguous lineage →

Recent News & Research

No recent news articles indexed yet for Acute leukemia of ambiguous lineage.
Search PubMed for Acute leukemia of ambiguous lineage →

Browse all Acute leukemia of ambiguous lineage news →

Specialist Network

Top 6 by expertise

Timothy Olson, MD, PhD

Children's Hospital of Philadelphia

Score 218 trials

Elias Jabbour, M.D

M.D. Anderson Cancer Center

📍 HOUSTON, TX

Score 129 trials

Marie Bleakley, MD

Fred Hutch/University of Washington Cancer Consortium

📍 SEATTLE, WA

Score 124 trials

Jennifer L McNeer, M.D

Children's Oncology Group

📍 CHICAGO, IL

Score 111 trial

Heather J Symons, M.D

Children's Oncology Group

📍 BALTIMORE, MD

Score 111 trial

Courtney DiNardo, MD

M.D. Anderson Cancer Center

📍 HOUSTON, TX

Score 103 trials

View all Acute leukemia of ambiguous lineage specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰